Overview
Hirofumi Nagamatsu practices in Isehara, Japan. Nagamatsu is rated as an Advanced expert by MediFind in the treatment of Muscle Atrophy. Their top areas of expertise are Muscle Atrophy, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Percutaneous Coronary Intervention (PCI), and Angioplasty.
Their clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 12 articles in the study of Muscle Atrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Heart FailureNagamatsu isAdvanced. Learn about Heart Failure.
- Muscle AtrophyNagamatsu isAdvanced. Learn about Muscle Atrophy.
- Experienced
- Acute Coronary SyndromeNagamatsu isExperienced. Learn about Acute Coronary Syndrome.
- AngioplastyNagamatsu isExperienced. Learn about Angioplasty.
- Coronary Heart DiseaseNagamatsu isExperienced. Learn about Coronary Heart Disease.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Orthostatic HypotensionNagamatsu isExperienced. Learn about Orthostatic Hypotension.
- Percutaneous Coronary Intervention (PCI)